Rossella Lauria

3.8k total citations
61 papers, 1.9k citations indexed

About

Rossella Lauria is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Cancer Research. According to data from OpenAlex, Rossella Lauria has authored 61 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 35 papers in Oncology, 22 papers in Pulmonary and Respiratory Medicine and 14 papers in Cancer Research. Recurrent topics in Rossella Lauria's work include Cancer Treatment and Pharmacology (20 papers), Ovarian cancer diagnosis and treatment (13 papers) and HER2/EGFR in Cancer Research (11 papers). Rossella Lauria is often cited by papers focused on Cancer Treatment and Pharmacology (20 papers), Ovarian cancer diagnosis and treatment (13 papers) and HER2/EGFR in Cancer Research (11 papers). Rossella Lauria collaborates with scholars based in Italy, United States and France. Rossella Lauria's co-authors include Sabino De Placido, Michelino De Laurentiis, Chiara Carlomagno, Ciro Gallo, Guido Pettinato, Luigi Panico, Alessandro Morabito, Angelo Raffaele Bianco, Francesco Perrone and Giuseppe Cancello and has published in prestigious journals such as Journal of Clinical Oncology, Cancer and Cancer Research.

In The Last Decade

Rossella Lauria

59 papers receiving 1.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Rossella Lauria Italy	18	1.2k	683	416	352	321	61	1.9k
Caroline Lohrisch Canada	23	1.3k 1.1×	934 1.4×	296 0.7×	410 1.2×	211 0.7×	80	2.1k
A. De Matteis Italy	21	1.2k 1.0×	809 1.2×	317 0.8×	533 1.5×	78 0.2×	58	2.1k
Marc Thill Germany	22	1.1k 0.9×	889 1.3×	253 0.6×	247 0.7×	205 0.6×	163	2.3k
Lars Ottestad Norway	15	1.2k 1.0×	517 0.8×	488 1.2×	583 1.7×	371 1.2×	35	1.7k
Alwynne Tidy United Kingdom	11	1.5k 1.2×	604 0.9×	302 0.7×	1.2k 3.4×	403 1.3×	17	2.2k
Ulla Glas Sweden	21	916 0.7×	772 1.1×	192 0.5×	875 2.5×	321 1.0×	44	2.1k
Uwe Langsenlehner Austria	28	896 0.7×	607 0.9×	754 1.8×	246 0.7×	98 0.3×	55	2.0k
Manuela Rabaglio Switzerland	22	1.2k 1.0×	819 1.2×	298 0.7×	779 2.2×	129 0.4×	83	2.0k
Ellen Schlichting Norway	21	834 0.7×	676 1.0×	420 1.0×	457 1.3×	100 0.3×	44	1.6k
Geraldine Walsh United Kingdom	17	1.6k 1.3×	1.4k 2.1×	382 0.9×	819 2.3×	160 0.5×	29	2.4k

Countries citing papers authored by Rossella Lauria

Since Specialization

Citations

This map shows the geographic impact of Rossella Lauria's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rossella Lauria with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rossella Lauria more than expected).

Fields of papers citing papers by Rossella Lauria

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rossella Lauria. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rossella Lauria. The network helps show where Rossella Lauria may publish in the future.

Co-authorship network of co-authors of Rossella Lauria

This figure shows the co-authorship network connecting the top 25 collaborators of Rossella Lauria. A scholar is included among the top collaborators of Rossella Lauria based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rossella Lauria. Rossella Lauria is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Angelis, Carmine De, Dario Bruzzese, Antônio Bernardo, et al.. (2021). Eribulin in combination with bevacizumab as second-line treatment for HER2-negative metastatic breast cancer progressing after first-line therapy with paclitaxel and bevacizumab: a multicenter, phase II, single arm trial (GIM11-BERGI). ESMO Open. 6(2). 100054–100054. 9 indexed citations

Arpino, Grazia, Carmine De Angelis, Pietro De Placido, et al.. (2020). Optimising triage procedures for patients with cancer needing active anticancer treatment in the COVID-19 era. ESMO Open. 5(5). e000885–e000885. 8 indexed citations

Montanari, Micaela, Vittoria Carbone, Luigi Coppola, et al.. (2018). Epigenetic Silencing of THY1 Tracks the Acquisition of the Notch1–EGFR Signaling in a Xenograft Model of CD44+/CD24low/CD90+ Myoepithelial Cells. Molecular Cancer Research. 17(2). 628–641. 7 indexed citations

Buono, Giuseppe, Mario Giuliano, Carmine De Angelis, et al.. (2017). Pretreatment Serum Concentration of Vitamin D and Breast Cancer Characteristics: A Prospective Observational Mediterranean Study. Clinical Breast Cancer. 17(7). 559–563. 12 indexed citations

Gargiulo, Piera, Matilde Pensabene, Monica Milano, et al.. (2016). Long-term survival and BRCA status in male breast cancer: a retrospective single-center analysis. BMC Cancer. 16(1). 375–375. 32 indexed citations

Arpino, Grazia, Carmine De Angelis, Giuseppe Buono, et al.. (2015). Metabolic and anthropometric changes in early breast cancer patients receiving adjuvant therapy. Breast Cancer Research and Treatment. 154(1). 127–132. 36 indexed citations

Danzi, Michele, et al.. (2013). Decision making in borderline ovarian tumors: report of a rare case of mesosigma psammocarcinoma.. PubMed. 84(ePub). 3 indexed citations

Mangili, Giorgia, Cristina Sigismondi, Luigi Frigerio, et al.. (2013). Recurrent granulosa cell tumors (GCTs) of the ovary: A MITO-9 retrospective study. Gynecologic Oncology. 130(1). 38–42. 39 indexed citations

Pignata, Sandro, Giovanni Scambia, Rossella Lauria, et al.. (2013). A randomized multicenter phase III study comparing weekly versus every 3 weeks carboplatin (C) plus paclitaxel (P) in patients with advanced ovarian cancer (AOC): Multicenter Italian Trials in Ovarian Cancer (MITO-7)—European Network of Gynaecological Oncological Trial Groups (ENGOT-ov-10) and Gynecologic Cancer Intergroup (GCIG) trial.. Journal of Clinical Oncology. 31(18_suppl). LBA5501–LBA5501. 7 indexed citations

10.

Fabbrocini, Gabriella, Luigia Panariello, Matilde Pensabene, et al.. (2013). EMPACT Syndrome Associated with Phenobarbital. Dermatitis. 24(1). 37–39. 5 indexed citations

11.

Pisano, Carmela, Alessandro Morabito, Roberto Sorio, et al.. (2009). A phase II study of capecitabine in the treatment of ovarian cancer resistant or refractory to platinum therapy: a multicentre Italian trial in ovarian cancer (MITO-6) trial. Cancer Chemotherapy and Pharmacology. 64(5). 1021–1027. 7 indexed citations

12.

Montagna, Emilia, Giuseppe Cancello, Diana D’Agostino, et al.. (2008). Central nervous system metastases in a cohort of metastatic breast cancer patients treated with trastuzumab. Cancer Chemotherapy and Pharmacology. 63(2). 275–280. 27 indexed citations

13.

Placido, Sabino De, Michelino De Laurentiis, M. De Lena, et al.. (2005). A randomised factorial trial of sequential doxorubicin and CMF vs CMF and chemotherapy alone vs chemotherapy followed by goserelin plus tamoxifen as adjuvant treatment of node-positive breast cancer. British Journal of Cancer. 92(3). 467–474. 24 indexed citations

14.

Placido, Sabino De, Rossella Lauria, Francesco Perrone, et al.. (2000). Vinorelbine + Mitomycin C as Second-Line Treatment of Metastatic Breast Cancer: A Two-Stage Phase 2 Study. Oncology. 58(1). 8–14. 7 indexed citations

15.

Carlomagno, Chiara, Francesco Perrone, Ciro Gallo, et al.. (1996). c-erb B2 overexpression decreases the benefit of adjuvant tamoxifen in early-stage breast cancer without axillary lymph node metastases.. Journal of Clinical Oncology. 14(10). 2702–2708. 328 indexed citations

16.

Placido, Sabino De, Francesco Perrone, Chiara Carlomagno, et al.. (1995). CMF vs alternating CMF/EV in the adjuvant treatment of operable breast cancer. A single centre randomised clinical trial (Naples GUN-3 study). British Journal of Cancer. 71(6). 1283–1287. 28 indexed citations

17.

Perrone, Federica, Chiara Carlomagno, Sabino De Placido, et al.. (1995). First-line systemic therapy for metastatic breast cancer and management of pleural effusion. Annals of Oncology. 6(10). 1033–1043. 4 indexed citations

18.

Palmieri, Gabriella, Alessandro Morabito, Rossella Lauria, et al.. (1993). Low-dose dopamine induces early recovery of recombinant interleukin-2—Impaired renal function. European Journal of Cancer. 29(8). 1119–1122. 14 indexed citations

19.

Bianco, Angelo Raffaele, Stefano De Stefani, Cesare Gridelli, et al.. (1991). Intensive Alternating Combination Chemotherapy and High Dose Chest Radiotherapy in Small Cell Lung Cancer. Tumori Journal. 77(5). 437–441. 2 indexed citations

20.

Simone, Giovanni de, et al.. (1985). Slow-release nifedipine versus placebo in the treatment of arterial hypertension. A double blind ergometric evaluation of cardiac workload.. Japanese Heart Journal. 26(2). 219–225. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact